Acorn Capital Advisors, LLC Top Holdings and 13F Report (2026) About Acorn Capital Advisors, LLCInvestment ActivityAcorn Capital Advisors, LLC has $366.46 million in total holdings as of June 30, 2026.Acorn Capital Advisors, LLC owns shares of 20 different stocks, but just 8 companies or ETFs make up 80% of its holdings.Approximately 5.76% of the portfolio was purchased this quarter.About 32.49% of the portfolio was sold this quarter.This quarter, Acorn Capital Advisors, LLC has purchased 22 new stocks and bought additional shares in 5 stocks.Acorn Capital Advisors, LLC sold shares of 3 stocks and completely divested from 3 stocks this quarter.Largest Holdings CG ONCOLOGY INC $80,393,115Urogen Pharma $61,581,856Trevi Therapeutics $40,001,341Candel Therapeutics $36,028,864Puma Biotechnology $33,504,835 Largest New Holdings this Quarter 29286X101 - EUGENE THERAPEUTICS $2,199,275 Holding Largest Purchases this Quarter KARYOPHARM THERAPEUTICS INC 1,230,287 shares (about $12.02M)JADE BIOSCEINCES INC 200,000 shares (about $4.44M)Aura Biosciences 333,333 shares (about $2.37M)EUGENE THERAPEUTICS 1,271,257 shares (about $2.20M)CG ONCOLOGY INC 999 shares (about $70.98K) Largest Sales this Quarter BioAtla 5,298,219 shares (about $21.93M)Q32 BIO INC. 98,881 shares (about $1.26M)BICARA THERAPEUTICS 1 shares (about $29.69) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcorn Capital Advisors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCG ONCOLOGY INC$80,393,115$70,979 â–²0.1%1,131,50021.9%COMURGNUrogen Pharma$61,581,8560.0%1,673,42016.8%HealthcareTRVITrevi Therapeutics$40,001,3410.0%2,144,84410.9%HealthcareCADLCandel Therapeutics$36,028,8640.0%3,497,9489.8%HealthcarePBYIPuma Biotechnology$33,504,8350.0%4,131,2999.1%HealthcareJADE BIOSCEINCES INC$21,925,807$4,444,000 â–²25.4%986,7606.0%COM NEWBICARA THERAPEUTICS$19,102,000$30 â–¼0.0%643,3815.2%COMKARYOPHARM THERAPEUTICS INC$14,831,964$12,019,904 â–²427.4%1,518,1134.0%COMMON STOCKONKURE THERAPEUTICS INC$12,948,9130.0%2,839,6743.5%CLASS A COMHELUS PHARMA INC.$10,181,1590.0%1,540,2662.8%COM STKTARAProtara Therapeutics$6,693,0790.0%1,752,1151.8%HealthcareAURAAura Biosciences$6,596,447$2,366,664 â–²56.0%929,0771.8%HealthcareLEONABIO, INC.$5,831,4130.0%634,5391.6%COMMON STOCKVSTMVerastem$5,612,1640.0%1,469,1531.5%HealthcareAADIAadi Bioscience$5,218,2830.0%1,139,3631.4%HealthcareQ32 BIO INC.$2,754,019$1,259,744 â–¼-31.4%216,1710.8%COMEUGENE THERAPEUTICS$2,199,275$2,199,275 â–²New Holding1,271,2570.6%COMJASPER THERAPEUTICS$604,027$11,200 â–²1.9%1,438,1590.2%COMBCABBioAtla$447,645$21,934,791 â–¼-98.0%108,1260.1%HealthcareVYNEVYNE Therapeutics$9260.0%1,4250.0%HealthcareTERNTerns Pharmaceuticals$0$92,063,038 â–¼-100.0%00.0%HealthcareCRDFCardiff Oncology$0$2,854,576 â–¼-100.0%00.0%HealthcareXFORX4 Pharmaceuticals$0$966,583 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
